Industry Developments

Poland's leading domestic drugmaker, Polpharma, is to buy a 33.3% stake in Bioton for an initial PLN450mn (US$198.9mn), the biotechnology company said on August 15 2008. The deal... 2008-08-19

Russian drugmaker Veropharm is set for another year of record sales after posting sales of US$86.5mn in H108, up 45.4% year-on-year (y-o-y). Driven by a thriving local market and... 2008-08-15

Hungary's Egis - like domestic rival Gedeon Richter - is having to deal with external pressures on both the domestic and foreign fronts in 2008, as sales for Q208 (FYQ3) dropped 5%... 2008-08-14

Poland's Treasury Ministry appears confident that the privatisation of 740 state-owned companies will be completed by 2011, despite the recent announcement that expectations for 2008... 2008-08-13

Considered by many industry observers - BMI included - as one of the highest potential pharmaceutical markets for drugmakers over the next five years, Turkey is attracting a multitude... 2008-08-12

US pharmaceutical giant Pfizer is looking to build a new R&D centre in Central and Eastern Europe (CEE), with Hungary one of the key contenders. According to the head of Pfizer's... 2008-08-05

New legislation limiting the ownership of pharmacies to four per person or company was adopted in Bulgaria on July 31 2008, after its second reading in parliament. The new rules also... 2008-08-04

Hungary's national health insurance fund (OEP) is set to make a profit of up to HUF10bn (US$67mn) in 2008, according to health minister Tamás Székely. Although this suggests that... 2008-08-04

The first half of 2008 has brought mixed results for pharmaceutical companies operating in Romania. Often considered as a high potential market for investment, it appears that the... 2008-07-31

Czech generics specialist Zentiva has said it expects sales to reach CZK8.9bn for the first half of 2008, a 32% year-on-year (y-o-y) growth. A continuing decline in sales in its key... 2008-07-25